查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617124

到 2030 年内视镜逆行性造影设备市场预测：按产品类型、技术、应用、最终用户和地区进行的全球分析

Endoscopic Retrograde Cholangiopancreatography Devices Market Forecasts to 2030 - Global Analysis by Product, Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球内视镜逆行性造影（ERCP）设备市场规模为 16.286 亿美元，预测期内复合年增长率为 8.3%，预计到 2030 年将达到 26 亿美元。

内视镜逆行性造影（ERCP）设备是用于诊断和治疗胆胰管的专用医疗设备。 ERCP结合内视镜和透视检查来观察和治疗恶性、狭窄和胆管结石。在手术过程中，将软式内视镜经由口腔插入十二指肠。然后使用切片检查钳、扩张器、支架和导管等专用仪器清除堵塞物、放置支架并收集组织样本。 ERCP 机器对于胰臟和胆道疾病的诊断和治疗至关重要，因为它们提供了高精度和微创的解决方案。

根据美国国家癌症资料库，美国68.5% 的胰臟癌诊断是在 65 岁及以上的人群中进行的。

胆道和胰臟疾病的盛行率增加

胆结石、胆道狭窄和胰臟炎等胆胰疾病的盛行率不断增加，推动了对内视镜逆行性造影（ERCP）设备的需求。这些疾病的有效治疗取决于准确的诊断和治疗，而ERCP手术至关重要。病例数的不断增加，尤其是老年人病例数量的增加，正在推动 ERCP 设备的使用并推动市场扩张。随着微创治疗和 ERCP 的早期检测改善患者的治疗效果，市场正在进一步扩大。

ERCP 程序和设备高成本

ERCP 手术和设备的高成本阻碍了市场扩张，特别是在医疗资源有限的低收入和中等收入国家。对专家的需求、高昂的设备成本和手术成本可能会阻碍医院和诊所实施 ERCP 技术。此外，儘管 ERCP 设备具有治疗功效，但阻碍其广泛采用的是保险范围和支付问题，这可能会限制患者接受这些尖端手术。

微创手术的进展

微创手术的进步透过提高治疗准确性和安全性对 ERCP 设备市场产生重大影响。改进的内视镜影像、更紧凑和灵活的设备以及复杂的切片检查仪器都是技术创新的例子，这些技术创新可以实现更好的治疗结果和诊断，同时缩短患者的康復时间。随着患者选择侵入性较小的替代标准手术，ERCP 机器的需求不断增加。这些发展也增加了治疗选择、减少问题并简化程序，支持市场成长。

併发症的风险

胰臟炎、出血、感染疾病等併发症的风险阻碍了ERCP设备的广泛使用。特别是在高风险情况下，这些风险可能会阻碍患者选择 ERCP，也可能会阻碍医疗保健提供者对其提供支援。此外，并非所有设施都能够安全地执行如此先进的程序，这需要高素质的专业人员来缓解困难，增加成本并可能阻碍市场扩张。

COVID-19 的影响：

COVID-19 的爆发严重影响了内视镜逆行性造影(ERCP) 设备市场，由于医疗保健系统的压力，导致选择性手术的延误和取消。因此，对 ERCP 设备的需求有所下降。然而，随着医疗保健系统的復苏，微创诊断和治疗技术，尤其是胃肠道和胆道疾病的微创诊断和治疗技术越来越受到关注，市场预计将復苏。

切片检查钳领域预计将成为预测期内最大的市场

由于胰臟和胆道疾病对准确诊断技术的需求不断增加，切片检查钳细分市场预计将在预测期内成为最大的市场。在 ERCP 过程中，切片检查钳可以采集组织样本，有助于早期诊断狭窄、癌症和其他异常情况。由于胃肠道疾病的增加和微创手术的改进，切片检查钳的使用正在增加。提高安全性和准确性是另外两个支持市场扩张的设计因素。

预计扩张器产业在预测期内的复合年增长率最高。

由于胆道疾病的盛行率不断上升、微创手术技术的进步以及对精确有效手术的需求不断增长，预计扩张器领域在预测期内将出现最高的复合年增长率。为了确保内视镜顺利通过，需要使用扩张器来扩张胰管或胆管的狭窄处。由于一次性用品、人体工学设计和增强的安全功能（方便扩张器的使用）等技术进步，ERCP 设备市场正在扩大。

比最大的地区

由于胰臟炎、胆管癌和胆结石等胆道疾病的盛行率不断增加，预计北美将在预测期内占据最大的市场占有率。 ERCP 设备的技术发展提高了治疗准确性和患者治疗效果，包括增强的影像系统和微创治疗。此外，该地区较高的医疗保健支出、完善的医疗保健基础设施以及尖端医疗技术利用率的不断提高，支持了对 ERCP 设备不断增长的需求，推动了市场扩张。

复合年增长率最高的地区：

由于医疗基础设施的增加、胆道和胰臟疾病发病率的上升以及人口老化的加剧，预计亚太地区在预测期内的复合年增长率最高。 ERCP 技术的进步，包括诊断影像和微创技术的改进，正在提高诊断和治疗能力。此外，扩大该地区的医疗服务范围、增加医疗旅游以及先进医疗设备的采用正在推动对 ERCP 设备的需求，刺激亚太地区的市场成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球经内视镜逆行性胆胰管摄影术（ERCP）设备市场：依产品

  • 内视镜治疗装置
  • 内视镜
  • 影像装置
  • 括约肌切开术
  • 支架
  • 球囊导管
  • 切片检查钳
  • 导管导引线
  • 扩张器
  • 其他产品

第六章全球经内视镜逆行性胆胰管摄影术(ERCP) 设备市场：依类型

  • 传统ERCP
  • 单操作员 ERCP
  • 腹腔镜ERCP
  • 超音波(EUS) 引导下的 ERCP
  • 其他类型

第七章全球经内视镜逆行性胆胰管摄影术（ERCP）设备市场：依技术分类

  • 先进的成像系统
  • 机器人辅助ERCP
  • 与人工智慧和机器学习集成
  • 其他技术

第八章全球经内视镜逆行性胆胰管摄影术（ERCP）设备市场：依应用分类

  • 诊断性ERCP
    • 胆管癌
    • 胰臟炎
    • 胆结石
    • 胆管狭窄
  • 治疗性ERCP
    • 石材开采
    • 支架置入
    • 括约肌切开术
    • 狭窄扩张
    • 排放受感染的胆汁
  • 其他用途

第 9 章全球经内视镜逆行性胆胰管摄影术(ERCP) 设备市场：依最终使用者分类

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 研究/学术机构
  • 其他最终用户

第10章全球经内视镜逆行性胆胰管摄影术（ERCP）设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • AMBU, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group
  • FUJIFILM Holdings Corporation
  • Hobbs Medical, Inc.
  • HOYA Group
  • Karl Storz SE & Co. KG
  • Medi-Globe GmbH
  • Medline Industries, Inc.
  • Medtronic PLC
  • Olympus Corporation
  • Streis PLC
  • Stryker Corporation
  • Taewoong Medical Co., Ltd.
  • Telemed System, Inc.
Product Code: SMRC28002

According to Stratistics MRC, the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market is accounted for $1628.6 million in 2024 and is expected to reach $2627.7 million by 2030 growing at a CAGR of 8.3% during the forecast period. Endoscopic Retrograde Cholangiopancreatography (ERCP) devices are specialist medical equipment used to perform diagnostic and therapeutic treatments on the bile and pancreatic channels. Endoscopy and fluoroscopy are combined in ERCP to view and treat malignancies, strictures, and bile duct stones. A flexible endoscope is inserted through the mouth into the duodenum during the surgery. There, specialized tools such as biopsy forceps, dilators, stents, and catheters are used to clear blockages, put stents, or take tissue samples. Because they provide highly accurate, minimally invasive solutions, ERCP devices are essential for the diagnosis and treatment of pancreatic and biliary disorders.

According to the National Cancer Database, 68.5% of pancreatic cancer diagnoses in the United States are made in people over 65 years old.

Market Dynamics:

Driver:

Increasing Prevalence of Biliary and Pancreatic Disorders

The growing prevalence of biliary and pancreatic illnesses, such as gallstones, bile duct strictures, and pancreatitis, pushes up demand for Endoscopic Retrograde Cholangiopancreatography (ERCP) equipment. Effective management of these disorders depends on precise diagnosis and treatment, which makes ERCP procedures crucial. The growing number of instances, especially in older populations, encourages the use of ERCP devices and propels market expansion. The market is further expanded by ERCP's minimally invasive treatments and early identification, which enhance patient outcomes.

Restraint:

High Cost of ERCP Procedures and Devices

The high cost of ERCP procedures and equipment stifles market expansion, especially in low- and middle-income countries with restricted healthcare resources. The necessity for specialist personnel, high equipment costs, and procedural expenses may discourage hospitals and clinics from implementing ERCP technology. Further impeding the broad adoption of ERCP devices despite their therapeutic benefits are insurance coverage and payment issues, which can limit patient access to these cutting-edge procedures.

Opportunity:

Advancements in Minimally Invasive Procedures

Advances in minimally invasive techniques have a substantial impact on the ERCP device market by improving treatment precision and safety. Improved endoscopic imaging, more compact and flexible devices, and sophisticated biopsy instruments are examples of innovations that allow for better therapy results and diagnostics while shortening recuperation periods for patients. ERCP devices are becoming more and more in demand as patients choose less intrusive alternatives to standard surgery. These developments also increase treatment options, decrease problems, and streamline procedures, which support the market's growth.

Threat:

Risk of Complications

The risk of complications, such as pancreatitis, bleeding, or infections, prevents widespread use of ERCP devices. Particularly in high-risk situations, these possible hazards can discourage patients from choosing ERCP procedures and medical professionals from endorsing them. Additionally, as not all facilities may be prepared to carry out such sophisticated procedures safely; the requirement for highly qualified experts to reduce difficulties can raise costs and hinder market expansion.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Endoscopic Retrograde Cholangiopancreatography (ERCP) devices market, leading to delays and cancellations of elective procedures due to healthcare system strain. This resulted in reduced demand for ERCP devices. However, as healthcare systems recover, the market is expected to rebound with increased focus on minimally invasive diagnostic and therapeutic procedures, particularly for gastrointestinal and biliary disorders.

The biopsy forceps segment is expected to be the largest during the forecast period

The biopsy forceps segment is expected to be the largest during the forecast period because there is a growing need for precise diagnostic techniques for pancreatic and biliary disorders. During ERCP, biopsy forceps make it possible to take tissue samples, which aids in the early diagnosis of strictures, cancer, and other anomalies. The use of biopsy forceps is increased by the growing incidence of gastrointestinal disorders and improvements in minimally invasive procedures. Improved safety and accuracy are two more design elements that support market expansion.

The dilators segment is expected to have the highest CAGR during the forecast period

The dilators segment is expected to have the highest CAGR during the forecast period owing to the rising prevalence of biliary problems, advances in minimally invasive surgical techniques, and the increased desire for precise and effective procedures. In order to ensure smoother endoscope transit, dilators are necessary to dilate the strictures in the pancreatic and bile ducts. The market for ERCP devices is expanding as a result of technological advancements such disposable, ergonomic designs, and enhanced safety features that encourage the use of dilators.

Region with largest share:

North America is anticipated to hold the largest market share during the forecast period because biliary tract conditions like pancreatitis, cholangiocarcinoma, and gallstones are becoming more common. Treatment accuracy and patient outcomes are being improved by technological developments in ERCP devices, including as enhanced imaging systems and minimally invasive treatments. Furthermore, the region's high healthcare spending, well-established healthcare infrastructure, and rising use of cutting-edge medical technology all support the rising demand for ERCP devices, which in turn propels the market's expansion.

Region with highest CAGR:

Asia Pacific is anticipated to witness the highest CAGR over the forecast period due to increasing healthcare infrastructure, rising incidences of biliary and pancreatic diseases, and a growing aging population. Advancements in ERCP technologies, such as improved imaging and minimally invasive techniques, are enhancing diagnostic and therapeutic capabilities. Additionally, the region's expanding healthcare access, rising medical tourism and adoption of advanced medical devices are boosting the demand for ERCP devices, fueling market growth in Asia Pacific.

Key players in the market

Some of the key players in Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market include AMBU, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, Cook Group, FUJIFILM Holdings Corporation, Hobbs Medical, Inc., HOYA Group, Karl Storz SE & Co. KG, Medi-Globe GmbH, Medline Industries, Inc., Medtronic PLC, Olympus Corporation, Streis PLC, Stryker Corporation, Taewoong Medical Co., Ltd. and Telemed System, Inc.

Key Developments:

In September 2024, Medtronic expanded AiBLE spine surgery ecosystem with new technologies and Siemens Healthineers partnership.

In April 2024, Medtronic plc announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO(TM), the latest generation software for the GI Genius(TM) intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.

In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, to offer continued innovation and scalable healthcare advancements for patients and caregivers globally.

Products Covered:

  • Endotherapy Devices
  • Endoscopes
  • Imaging Devices
  • Sphincterotomes
  • Stents
  • Balloon Catheters
  • Biopsy Forceps
  • Guidewires
  • Dilators
  • Other Products

Types Covered:

  • Conventional ERCP
  • Single-Operator ERCP
  • Laparoscopic ERCP
  • Endoscopic Ultrasound (EUS)-Guided ERCP
  • Other Types

Technologies Covered:

  • Advanced Imaging Systems
  • Robotic-Assisted ERCP
  • Integration with AI and Machine Learning
  • Other Technologies

Applications Covered:

  • Diagnostic ERCP
  • Therapeutic ERCP
  • Other Applications

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Research and Academic Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Endotherapy Devices
  • 5.3 Endoscopes
  • 5.4 Imaging Devices
  • 5.5 Sphincterotomes
  • 5.6 Stents
  • 5.7 Balloon Catheters
  • 5.8 Biopsy Forceps
  • 5.9 Guidewires
  • 5.10 Dilators
  • 5.11 Other Products

6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Type

  • 6.1 Introduction
  • 6.2 Conventional ERCP
  • 6.3 Single-Operator ERCP
  • 6.4 Laparoscopic ERCP
  • 6.5 Endoscopic Ultrasound (EUS)-Guided ERCP
  • 6.6 Other Types

7 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Technology

  • 7.1 Introduction
  • 7.2 Advanced Imaging Systems
  • 7.3 Robotic-Assisted ERCP
  • 7.4 Integration with AI and Machine Learning
  • 7.5 Other Technologies

8 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Diagnostic ERCP
    • 8.2.1 Cholangiocarcinoma
    • 8.2.2 Pancreatitis
    • 8.2.3 Gallstones
    • 8.2.4 Biliary Strictures
  • 8.3 Therapeutic ERCP
    • 8.3.1 Stone Extraction
    • 8.3.2 Stent Placement
    • 8.3.3 Sphincterotomy
    • 8.3.4 Dilation of Strictures
    • 8.3.5 Drainage of Infected Bile
  • 8.4 Other Applications

9 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Specialty Clinics
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Research and Academic Institutions
  • 9.6 Other End Users

10 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AMBU, Inc.
  • 12.2 B. Braun Melsungen AG
  • 12.3 Boston Scientific Corporation
  • 12.4 CONMED Corporation
  • 12.5 Cook Group
  • 12.6 FUJIFILM Holdings Corporation
  • 12.7 Hobbs Medical, Inc.
  • 12.8 HOYA Group
  • 12.9 Karl Storz SE & Co. KG
  • 12.10 Medi-Globe GmbH
  • 12.11 Medline Industries, Inc.
  • 12.12 Medtronic PLC
  • 12.13 Olympus Corporation
  • 12.14 Streis PLC
  • 12.15 Stryker Corporation
  • 12.16 Taewoong Medical Co., Ltd.
  • 12.17 Telemed System, Inc.

List of Tables

  • Table 1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Endotherapy Devices (2022-2030) ($MN)
  • Table 4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Endoscopes (2022-2030) ($MN)
  • Table 5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Imaging Devices (2022-2030) ($MN)
  • Table 6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Sphincterotomes (2022-2030) ($MN)
  • Table 7 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Stents (2022-2030) ($MN)
  • Table 8 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Balloon Catheters (2022-2030) ($MN)
  • Table 9 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Biopsy Forceps (2022-2030) ($MN)
  • Table 10 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Guidewires (2022-2030) ($MN)
  • Table 11 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Dilators (2022-2030) ($MN)
  • Table 12 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 13 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Type (2022-2030) ($MN)
  • Table 14 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Conventional ERCP (2022-2030) ($MN)
  • Table 15 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Single-Operator ERCP (2022-2030) ($MN)
  • Table 16 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Laparoscopic ERCP (2022-2030) ($MN)
  • Table 17 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Endoscopic Ultrasound (EUS)-Guided ERCP (2022-2030) ($MN)
  • Table 18 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 19 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Technology (2022-2030) ($MN)
  • Table 20 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Advanced Imaging Systems (2022-2030) ($MN)
  • Table 21 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Robotic-Assisted ERCP (2022-2030) ($MN)
  • Table 22 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Integration with AI and Machine Learning (2022-2030) ($MN)
  • Table 23 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 24 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Diagnostic ERCP (2022-2030) ($MN)
  • Table 26 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Cholangiocarcinoma (2022-2030) ($MN)
  • Table 27 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Pancreatitis (2022-2030) ($MN)
  • Table 28 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Gallstones (2022-2030) ($MN)
  • Table 29 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Biliary Strictures (2022-2030) ($MN)
  • Table 30 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Therapeutic ERCP (2022-2030) ($MN)
  • Table 31 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Stone Extraction (2022-2030) ($MN)
  • Table 32 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Stent Placement (2022-2030) ($MN)
  • Table 33 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Sphincterotomy (2022-2030) ($MN)
  • Table 34 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Dilation of Strictures (2022-2030) ($MN)
  • Table 35 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Drainage of Infected Bile (2022-2030) ($MN)
  • Table 36 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 37 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 38 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 39 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 40 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 41 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Research and Academic Institutions (2022-2030) ($MN)
  • Table 42 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.